Hepatitis c and Atrial fibrillation/flutter

Summary:

Atrial fibrillation/flutter is found among people with Hepatitis c, especially for people who are male, 60+ old.

The study analyzes which people have Atrial fibrillation/flutter with Hepatitis c. It is created by eHealthMe based on reports of 452 people who have Hepatitis c from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatitis c?

Hepatitis c is found to be associated with 787 drugs and 984 conditions by eHealthMe. Check the latest studies of Hepatitis c.

What is Atrial fibrillation/flutter?

Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,364 drugs and 3,841 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.

On Jul, 16, 2026

452 people who have Hepatitis C and Atrial Fibrillation/Flutter are studied.

Would you have Atrial fibrillation/flutter when you have Hepatitis c?

Gender of people who have Hepatitis c and experienced Atrial fibrillation/flutter *:

Click here to view

Age of people who have Hepatitis c and experienced Atrial fibrillation/flutter *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Atrial fibrillation/flutter?

- Check whether Atrial fibrillation/flutter is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Hepatitis c (131,813 reports)
Atrial fibrillation/flutter (349,226 reports)

All the drugs that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (2,364 drugs)

All the conditions that are associated with Atrial fibrillation/flutter:

Atrial fibrillation/flutter (3,841 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Atrial fibrillation/flutter and Hepatitis c, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.